Recombinant thyrotropin versus thyroid hormone withdrawal in evaluating patients with thyroid carcinoma

Seminars in Nuclear Medicine

Volumn 30, Issue 2, 2000, Pages 98-106

  Ladenson, Paul W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN;

CELL DIFFERENTIATION; DIAGNOSTIC TEST; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG WITHDRAWAL; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; LABORATORY TEST; MINIMAL RESIDUAL DISEASE; REVIEW; THYROID CARCINOMA;

EID: 0034077606     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/nm.2000.4599     Document Type: Article

References (43)

1. Mazzaferri EL Jhiang SM Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 1994 418 428
2. Robbins J Merino MJ Boice JD Jr. Thyroid cancer: a lethal endocrine neoplasm Ann Intern Med 115 2 1991 133 147
3. Cancer Facts and Figures 1998 American Cancer Society Atlanta
4. National Cancer Institute Fact Book 1993 U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health
5. Ozata M Suzuki S Miyamoto T Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer J Clin Endocrinol Metab 74 1994 98 105
6. Pacini F Pinchera A Giani C Serum thyroglobulin concentrations and 1311 whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy) Clin Endocrinol (Oxf) 13 1980 107 110
7. Maxon HR Smith HS Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer Endocrinol Metab Clin North Am 19 1990 685 718
8. Schneider AB Line BR Goldman JM Sequential serum thyroglobulin determinations, 1311 scans, and 1311 uptakes after triiodothyronine withdrawal in patients with thyroid cancer J Clin Endocrinol Metab 53 1981 1199 1206
9. Goldman JM Line BR Aamodt RL Influence of triiodothyronine withdrawal time on 131-I uptake postthyroidectomy for thyroid cancer J Clin Endocrinol Metab 50 1980 734 739
10. Maloof F Vickery AL Rapp B An evaluation of various factors influencing the treatment of metastatic thyroid carcinoma with 1311 J Clin Endocrinol Metab 16 1956 1 27
11. Sfakianakis GN Skillman TG George JM Thyroxine withdrawal in thyroid cancer Ohio State Med J 71 1975 78 82
12. Goldberg LD Ditchek NT Thyroid carcinoma with spinal cord compression JAMA 246 1981 953 954
13. Ringel MD Ladenson PW Diagnostic accuracy of 1311 scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid cancer and hypopituitarism J Clin Endocrinol Metab 81 1996 1724 1725
14. Sturgeon CT Davis FE Catz B Treatment of thyroid cancer metastases with TSH and I-131 during thyroid hormone medication J Clin Endocrinol Metab 13 1953 1391 1407
15. Benua RS Sonenberg RS Leeper RD An 18 year study of the use of beef thyrotropin to increase I-131 uptake in metastatic thyroid cancer J Nucl Med 5 1964 796 801
16. Sherman WB Werner C Generalized allergic reaction to bovine thyrotropin JAMA 190 1964 244 245
17. Krishnamurthy GT Human reaction to bovine TSH: concise communication J Nucl Med 19 1978 284 286
18. Melmed S Harada A Hershman JM Neutralizing antibodies to bovine thyrotropin in immunized patients with thyroid cancer J Clin Endocrinol Metab 51 1980 358 363
19. Law A Jack GW Tellez M In-vivo studies of a human thyrotrophin preparation J Endocrinol 110 1986 375 378
20. Duick DS Wahner HW Edis AJ Effects of oral thyrotropin-releasing hormone, exogenous thyroid-stimulating hormone, and withdrawal of triiodothyronine on 131-I uptake after subtotal thyroidectomy J Clin Endocrinol Metab 50 3 1980 502 506
21. Robbins J The role of TRH and lithium in the management of thyroid cancer Andreoli M Monaco F Robbins J Advances in Thyroid Neoplasia 1981 Acta Medica Rome 233 243
22. Wondisford FE Radovick S Moates JM Isolation and characterization of the human thyrotropin beta-subunit gene. Differences in gene structure and promoter function from murine species J Biol Chem 263 1988 12538 12542
23. Szkudlinski MW Thotakura NR Bucci I Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: The role of sialylation and sulfation in TSH bioactivity Endocrinology 133 1993 1490 1503
24. Weintraub BD Szkudlinski MW Development and in vitro characterization of human recombinant thyrotropin Thyroid 9 1999 447 450
25. Suppl Weintraub BD Wondisford FE Farr EA Pretranslational and post-translational regulation of TSH: relationship to bioactivity Horm Metab Res 23 1990 9 11
26. Thotakura NR Desai RK Bates LG Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells Endocrinology 128 1991 341 348
27. Huber GK Fong P Concepcion ES Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells J Clin Endocrinol Metab 72 1991 1328 1331
28. Braverman LE Pratt BM Ebner S Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the Rhesus monkey J Clin Endocrinol Metab 74 1992 1135 1139
29. Park H-M Perkins OW Edmondson JW Influence of diagnostic radioiodine on the uptake of ablative doses of iodine-131 Thyroid 4 1994 49 54
30. Meier CA Braverman LE Ebner SA Diagnostic use of human recombinant thyrotropin in patients with thyroid carcinoma (phase I/II study) J Clin Endocrinol Metab 78 1994 188 196
31. Ladenson PW Braverman LE Mazzaferri EL Comparison of recombinant human thyrotropin administration to thyroid hormone withdrawal for radioactive iodine scanning in patients with thyroid carcinoma N Engl J Med 337 1997 888 896
32. Billewicz WZ Chapman RS Crooks J Statistical methods applied to the diagnosis of hypothyroidism QJM 38 1969 255 266
33. Albrecht RR Ewing SJ Standardizing the administration of the Profile of Mood States (POMS): development of alternative word lists J Pers Assess 53 1989 31 39
34. (abstract) Park S-G Reynolds JC Brucker-Davis F Iodine kinetics during 131-I scanning in patients with thyroid cancer: comparison of studies with recombinant human TSH (rhTSH) vs. hypothyroidism suppl, 15P J Nucl Med 37 1996
35. Graettinger JS Muenster JJ Checchia CS A correlation of clinical and hemodynamic studies in patients with hypotyroidism J Clin Invest 19 1958 502 510
36. Katz AI Emmanouel DS Lindheimer MD Thyroid hormone and the kidney Nephron 15 1975 223 249
37. Haugen BR Pacini F Reiners C A comparison of recombinant thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer J Clin Endocrinol Metab 84 1999 3877 3885
38. National Thyroid Cancer Treatment Cooperative Study Registry Group Sherman SI Brierley JD Sperling M Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome Cancer 83 1998 1012 1021
39. Lin JD Kao PF Weng HF Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma J Nucl Med 40 1999 963 967
40. Alam MS Kasagi K Misaki T Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation Thyroid 8 1998 1091 1100
41. Uematsu H Sadato N Ohtsubo T Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors Thyroid 9 1999 583 589
42. Valli N Catargi B Ronci N Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy J Nucl Med 39 1998 453 459
43. Ringel MD Ladenson PW Levine MA Molecular diagnosis of residual and recurrent thyroid cancer by amplifica2tion of thyroglobulin mRNA in peripheral blood cells J Clin Endocrinol Metab 83 1998 4435 4442